Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
D000206:Actuarial Analysis; D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D005260:Female; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage* / Q000009:adverse effects; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D003520:Cyclophosphamide; D007069:Ifosfamide